American College of Obstetricians and Gynecologists. Practice bulletins No. 172: premature rupture of membranes [J]. Obstet Gynecol, 2016, 128(4):e165-e177.
Bredeson S, Papaconstantinou J, Deford J H, et al. HMGB1 promotes a p38MAPK associated non-infectious inflammatory response pathway in human fetal membranes[J]. PLoS One, 2014, 9(12):e113799-e113799.
[7]
Musilova I, Andrys C.Amniotic fluid prostaglandin E2 in pregnancies complicated by preterm prelabor rupture of the membranes.[J]. J Matern Fetal Neonatal Med,2016,29(18):2915-2923.
[8]
Ilhan N, Celik E, Kumbak B. Maternal plasma levels of interleukin-6, C-reactive protein, vitamins C, E and A, 8-isoprostane and oxidative status in women with preterm premature rupture of membranes[J]. J Matern Fetal Neonatal Med, 2015, 28(3):316-319.
[9]
Rumbold A, Crowther C A. Vitamin C supplementation in pregnancy [J]. Cochrane Database Syst Rev, 2015, 9(2):CD004072.
[10]
Borgida A F, Mills A A, Feldman D M, et al.Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis[J]. Am J Obstet Gynecol, 2000,183(4): 937-939.
Van d M I, De J R, Duvekot J, et al. Maternal and neonatal outcomes of preterm premature rupture of membranes before viability[J]. Klin Padiatr, 2016, 228(2):222-228.
[13]
Lloreda-Garcia J M, Lorente-Nicolás A, Bermejo-Costa F, et al. Need for resuscitation in preterm neonates less than 32 weeks treated with antenatal magnesium sulphate for neuroprotection[J]. Rev Chil Pediatr, 2016, 87(4):261-267.
[14]
Jacquemyn Y, Zecic A, Van L D, et al. The use of intravenous magnesium in non-preeclamptic pregnant women: fetal/neonatal neuroprotection[J]. Arch Gynecol Obstet, 2015, 291(5): 969-975.
[15]
Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth [J]. Obstet Gynecol, 2006, 109(1):189-190.
[16]
Brookfield K F, Elsayed Y Y, Chao L, et al. Antenatal corticosteroids for preterm premature rupture of membranes: single or repeat course?[J]. Am J Perinatol, 2015, 32(6):537-544.
[17]
American College of Obstetricians and Gynecologists,Society for Maternal-Fetal Medicine[J]. ACOG Obstetric Care Consensus No. 3: Periviable Birth[J]. Obstet Gynecol, 2015, 126(5):82-94.
[18]
Gyamfi-Bannerman C, Thom E A, Blackwell S C,et al. Antenatal betamethasone for women at risk for late preterm delivery. NICHD Maternal-Fetal Medicine Units Network[J]. N Engl J Med, 2016,374(14):1311-1320.
[19]
[No authors listed]. Risk of preterm delivery: a single course of antenatal corticosteroids[J]. Prescrire Int, 2010, 19(108):168-169.
[20]
Kenyon S, Boulvain M, Neilson J P. Antibiotics for preterm rupture of membranes[M]// The Cochrane Library. John Wiley & Sons, Ltd, 2010 :CD001058-CD001058.
[21]
American College of Obstetricians and Gynecologists Committee on Obstetric Practice. ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns [J]. Obstet Gynecol, 2011,117(4):1019-1027.
[22]
American College of Obstetricians and Gynecologists. ACOG Practice bulletin No. 120: Use of prophylactic antibiotics in labor and delivery[J]. Obstet Gynecol,2011,117(6):1472-1483.
[23]
Lee J, Romero R, Kim S M, et al. A new antibiotic regimen treats and prevents intra-amniotic infection/inflammation in patients with preterm PROM[J].J Matern Fetal Neonatal Med, 2016, 29(17):1-44.
[24]
Ericson J E, Laughon M M. Chorioamnionitis: implications for the neonate[J]. Clin Perinatol, 2015, 42(1):155-165.
[25]
Papadopulos N A, Kyriakidis D I, Schillinger U, et al. Successful anatomic repair of fetoscopic access sites in the mid-gestational rabbit model using amnion cell engineering[J]. Vivo, 2010, 24(5):745-750.
[26]
Haller C M, Buerzle W, Kivelio A, et al. Mussel-mimetic tissue adhesive for fetal membrane repair: an ex vivo evaluation[J]. Acta Biomaterialia, 2012, 8(12):4365-4370.
2018, Vol. 29 
